Fexanto ER 40 Tablet contains Febuxostat 40mg, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid, thereby lowering serum urate levels and preventing gout attacks and the formation of urate crystals in joints and tissues. Fexanto ER 40 is an extended-release formulation designed to provide a consistent therapeutic effect over 24 hours, improving patient compliance with once-daily dosing. It is indicated for the long-term management of chronic gout and may be prescribed when patients are intolerant to or inadequately controlled by other urate-lowering therapies such as allopurinol. The medication should be taken as directed by a healthcare professional, usually once daily with or without food. Common side effects may include liver function abnormalities, nausea, joint pain, and rash; therefore, regular monitoring of liver enzymes and renal function is recommended during treatment. Fexanto ER 40 is contraindicated in patients with severe liver impairment and should be used cautiously in those with cardiovascular disease. It is important to maintain adequate hydration and avoid alcohol to reduce the risk of gout flare-ups during therapy.

Dosage & How to Use